The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Influenza Daignostic Market Research Report 2025
Synopsis
Increasing prevalence of influenza, growing awareness for early detection using specific diagnostic tests,
The global Influenza Daignostic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Influenza Daignostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Influenza Daignostic.
Report Scope
The Influenza Daignostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Influenza Daignostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Influenza Daignostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Abbott Laboratories
Danaher Corporation
Bio-Rad Laboratories
BIOMÉRIEUX
Roche
Becton Dickinson And Company
Meridian Bioscience
Quidel Corporation
Hologic
Segment by Type
Rapid Flu Detection Test
Virus Detection
Direct Fluorescent Antibody (DFA) Test
Serological Testing
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Influenza Daignostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Increasing prevalence of influenza, growing awareness for early detection using specific diagnostic tests,
The global Influenza Daignostic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Influenza Daignostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Influenza Daignostic.
Report Scope
The Influenza Daignostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Influenza Daignostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Influenza Daignostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Abbott Laboratories
Danaher Corporation
Bio-Rad Laboratories
BIOMÉRIEUX
Roche
Becton Dickinson And Company
Meridian Bioscience
Quidel Corporation
Hologic
Segment by Type
Rapid Flu Detection Test
Virus Detection
Direct Fluorescent Antibody (DFA) Test
Serological Testing
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Influenza Daignostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Influenza Daignostic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Rapid Flu Detection Test
1.2.3 Virus Detection
1.2.4 Direct Fluorescent Antibody (DFA) Test
1.2.5 Serological Testing
1.3 Market by Application
1.3.1 Global Influenza Daignostic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Influenza Daignostic Market Perspective (2019-2030)
2.2 Influenza Daignostic Growth Trends by Region
2.2.1 Global Influenza Daignostic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Influenza Daignostic Historic Market Size by Region (2019-2024)
2.2.3 Influenza Daignostic Forecasted Market Size by Region (2025-2030)
2.3 Influenza Daignostic Market Dynamics
2.3.1 Influenza Daignostic Industry Trends
2.3.2 Influenza Daignostic Market Drivers
2.3.3 Influenza Daignostic Market Challenges
2.3.4 Influenza Daignostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Influenza Daignostic Players by Revenue
3.1.1 Global Top Influenza Daignostic Players by Revenue (2019-2024)
3.1.2 Global Influenza Daignostic Revenue Market Share by Players (2019-2024)
3.2 Global Influenza Daignostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Influenza Daignostic Revenue
3.4 Global Influenza Daignostic Market Concentration Ratio
3.4.1 Global Influenza Daignostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Influenza Daignostic Revenue in 2023
3.5 Influenza Daignostic Key Players Head office and Area Served
3.6 Key Players Influenza Daignostic Product Solution and Service
3.7 Date of Enter into Influenza Daignostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Influenza Daignostic Breakdown Data by Type
4.1 Global Influenza Daignostic Historic Market Size by Type (2019-2024)
4.2 Global Influenza Daignostic Forecasted Market Size by Type (2025-2030)
5 Influenza Daignostic Breakdown Data by Application
5.1 Global Influenza Daignostic Historic Market Size by Application (2019-2024)
5.2 Global Influenza Daignostic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Influenza Daignostic Market Size (2019-2030)
6.2 North America Influenza Daignostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Influenza Daignostic Market Size by Country (2019-2024)
6.4 North America Influenza Daignostic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Influenza Daignostic Market Size (2019-2030)
7.2 Europe Influenza Daignostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Influenza Daignostic Market Size by Country (2019-2024)
7.4 Europe Influenza Daignostic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Influenza Daignostic Market Size (2019-2030)
8.2 Asia-Pacific Influenza Daignostic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Influenza Daignostic Market Size by Region (2019-2024)
8.4 Asia-Pacific Influenza Daignostic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Influenza Daignostic Market Size (2019-2030)
9.2 Latin America Influenza Daignostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Influenza Daignostic Market Size by Country (2019-2024)
9.4 Latin America Influenza Daignostic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Influenza Daignostic Market Size (2019-2030)
10.2 Middle East & Africa Influenza Daignostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Influenza Daignostic Market Size by Country (2019-2024)
10.4 Middle East & Africa Influenza Daignostic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Influenza Daignostic Introduction
11.1.4 Thermo Fisher Scientific Revenue in Influenza Daignostic Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Influenza Daignostic Introduction
11.2.4 Abbott Laboratories Revenue in Influenza Daignostic Business (2019-2024)
11.2.5 Abbott Laboratories Recent Development
11.3 Danaher Corporation
11.3.1 Danaher Corporation Company Detail
11.3.2 Danaher Corporation Business Overview
11.3.3 Danaher Corporation Influenza Daignostic Introduction
11.3.4 Danaher Corporation Revenue in Influenza Daignostic Business (2019-2024)
11.3.5 Danaher Corporation Recent Development
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Detail
11.4.2 Bio-Rad Laboratories Business Overview
11.4.3 Bio-Rad Laboratories Influenza Daignostic Introduction
11.4.4 Bio-Rad Laboratories Revenue in Influenza Daignostic Business (2019-2024)
11.4.5 Bio-Rad Laboratories Recent Development
11.5 BIOMÉRIEUX
11.5.1 BIOMÉRIEUX Company Detail
11.5.2 BIOMÉRIEUX Business Overview
11.5.3 BIOMÉRIEUX Influenza Daignostic Introduction
11.5.4 BIOMÉRIEUX Revenue in Influenza Daignostic Business (2019-2024)
11.5.5 BIOMÉRIEUX Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche Influenza Daignostic Introduction
11.6.4 Roche Revenue in Influenza Daignostic Business (2019-2024)
11.6.5 Roche Recent Development
11.7 Becton Dickinson And Company
11.7.1 Becton Dickinson And Company Company Detail
11.7.2 Becton Dickinson And Company Business Overview
11.7.3 Becton Dickinson And Company Influenza Daignostic Introduction
11.7.4 Becton Dickinson And Company Revenue in Influenza Daignostic Business (2019-2024)
11.7.5 Becton Dickinson And Company Recent Development
11.8 Meridian Bioscience
11.8.1 Meridian Bioscience Company Detail
11.8.2 Meridian Bioscience Business Overview
11.8.3 Meridian Bioscience Influenza Daignostic Introduction
11.8.4 Meridian Bioscience Revenue in Influenza Daignostic Business (2019-2024)
11.8.5 Meridian Bioscience Recent Development
11.9 Quidel Corporation
11.9.1 Quidel Corporation Company Detail
11.9.2 Quidel Corporation Business Overview
11.9.3 Quidel Corporation Influenza Daignostic Introduction
11.9.4 Quidel Corporation Revenue in Influenza Daignostic Business (2019-2024)
11.9.5 Quidel Corporation Recent Development
11.10 Hologic
11.10.1 Hologic Company Detail
11.10.2 Hologic Business Overview
11.10.3 Hologic Influenza Daignostic Introduction
11.10.4 Hologic Revenue in Influenza Daignostic Business (2019-2024)
11.10.5 Hologic Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Influenza Daignostic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Rapid Flu Detection Test
Table 3. Key Players of Virus Detection
Table 4. Key Players of Direct Fluorescent Antibody (DFA) Test
Table 5. Key Players of Serological Testing
Table 6. Global Influenza Daignostic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Influenza Daignostic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Influenza Daignostic Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Influenza Daignostic Market Share by Region (2019-2024)
Table 10. Global Influenza Daignostic Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Influenza Daignostic Market Share by Region (2025-2030)
Table 12. Influenza Daignostic Market Trends
Table 13. Influenza Daignostic Market Drivers
Table 14. Influenza Daignostic Market Challenges
Table 15. Influenza Daignostic Market Restraints
Table 16. Global Influenza Daignostic Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Influenza Daignostic Market Share by Players (2019-2024)
Table 18. Global Top Influenza Daignostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Daignostic as of 2023)
Table 19. Ranking of Global Top Influenza Daignostic Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Influenza Daignostic Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Influenza Daignostic Product Solution and Service
Table 23. Date of Enter into Influenza Daignostic Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Influenza Daignostic Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Influenza Daignostic Revenue Market Share by Type (2019-2024)
Table 27. Global Influenza Daignostic Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Influenza Daignostic Revenue Market Share by Type (2025-2030)
Table 29. Global Influenza Daignostic Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Influenza Daignostic Revenue Market Share by Application (2019-2024)
Table 31. Global Influenza Daignostic Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Influenza Daignostic Revenue Market Share by Application (2025-2030)
Table 33. North America Influenza Daignostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Influenza Daignostic Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Influenza Daignostic Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Influenza Daignostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Influenza Daignostic Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Influenza Daignostic Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Influenza Daignostic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Influenza Daignostic Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Influenza Daignostic Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Influenza Daignostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Influenza Daignostic Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Influenza Daignostic Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Influenza Daignostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Influenza Daignostic Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Influenza Daignostic Market Size by Country (2025-2030) & (US$ Million)
Table 48. Thermo Fisher Scientific Company Detail
Table 49. Thermo Fisher Scientific Business Overview
Table 50. Thermo Fisher Scientific Influenza Daignostic Product
Table 51. Thermo Fisher Scientific Revenue in Influenza Daignostic Business (2019-2024) & (US$ Million)
Table 52. Thermo Fisher Scientific Recent Development
Table 53. Abbott Laboratories Company Detail
Table 54. Abbott Laboratories Business Overview
Table 55. Abbott Laboratories Influenza Daignostic Product
Table 56. Abbott Laboratories Revenue in Influenza Daignostic Business (2019-2024) & (US$ Million)
Table 57. Abbott Laboratories Recent Development
Table 58. Danaher Corporation Company Detail
Table 59. Danaher Corporation Business Overview
Table 60. Danaher Corporation Influenza Daignostic Product
Table 61. Danaher Corporation Revenue in Influenza Daignostic Business (2019-2024) & (US$ Million)
Table 62. Danaher Corporation Recent Development
Table 63. Bio-Rad Laboratories Company Detail
Table 64. Bio-Rad Laboratories Business Overview
Table 65. Bio-Rad Laboratories Influenza Daignostic Product
Table 66. Bio-Rad Laboratories Revenue in Influenza Daignostic Business (2019-2024) & (US$ Million)
Table 67. Bio-Rad Laboratories Recent Development
Table 68. BIOMÉRIEUX Company Detail
Table 69. BIOMÉRIEUX Business Overview
Table 70. BIOMÉRIEUX Influenza Daignostic Product
Table 71. BIOMÉRIEUX Revenue in Influenza Daignostic Business (2019-2024) & (US$ Million)
Table 72. BIOMÉRIEUX Recent Development
Table 73. Roche Company Detail
Table 74. Roche Business Overview
Table 75. Roche Influenza Daignostic Product
Table 76. Roche Revenue in Influenza Daignostic Business (2019-2024) & (US$ Million)
Table 77. Roche Recent Development
Table 78. Becton Dickinson And Company Company Detail
Table 79. Becton Dickinson And Company Business Overview
Table 80. Becton Dickinson And Company Influenza Daignostic Product
Table 81. Becton Dickinson And Company Revenue in Influenza Daignostic Business (2019-2024) & (US$ Million)
Table 82. Becton Dickinson And Company Recent Development
Table 83. Meridian Bioscience Company Detail
Table 84. Meridian Bioscience Business Overview
Table 85. Meridian Bioscience Influenza Daignostic Product
Table 86. Meridian Bioscience Revenue in Influenza Daignostic Business (2019-2024) & (US$ Million)
Table 87. Meridian Bioscience Recent Development
Table 88. Quidel Corporation Company Detail
Table 89. Quidel Corporation Business Overview
Table 90. Quidel Corporation Influenza Daignostic Product
Table 91. Quidel Corporation Revenue in Influenza Daignostic Business (2019-2024) & (US$ Million)
Table 92. Quidel Corporation Recent Development
Table 93. Hologic Company Detail
Table 94. Hologic Business Overview
Table 95. Hologic Influenza Daignostic Product
Table 96. Hologic Revenue in Influenza Daignostic Business (2019-2024) & (US$ Million)
Table 97. Hologic Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Influenza Daignostic Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Influenza Daignostic Market Share by Type: 2023 VS 2030
Figure 3. Rapid Flu Detection Test Features
Figure 4. Virus Detection Features
Figure 5. Direct Fluorescent Antibody (DFA) Test Features
Figure 6. Serological Testing Features
Figure 7. Global Influenza Daignostic Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Influenza Daignostic Market Share by Application: 2023 VS 2030
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Influenza Daignostic Report Years Considered
Figure 13. Global Influenza Daignostic Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Influenza Daignostic Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Influenza Daignostic Market Share by Region: 2023 VS 2030
Figure 16. Global Influenza Daignostic Market Share by Players in 2023
Figure 17. Global Top Influenza Daignostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Daignostic as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Influenza Daignostic Revenue in 2023
Figure 19. North America Influenza Daignostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Influenza Daignostic Market Share by Country (2019-2030)
Figure 21. United States Influenza Daignostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Influenza Daignostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Influenza Daignostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Influenza Daignostic Market Share by Country (2019-2030)
Figure 25. Germany Influenza Daignostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Influenza Daignostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Influenza Daignostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Influenza Daignostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Influenza Daignostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Influenza Daignostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Influenza Daignostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Influenza Daignostic Market Share by Region (2019-2030)
Figure 33. China Influenza Daignostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Influenza Daignostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Influenza Daignostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Influenza Daignostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Influenza Daignostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Influenza Daignostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Influenza Daignostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Influenza Daignostic Market Share by Country (2019-2030)
Figure 41. Mexico Influenza Daignostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Influenza Daignostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Influenza Daignostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Influenza Daignostic Market Share by Country (2019-2030)
Figure 45. Turkey Influenza Daignostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Influenza Daignostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Influenza Daignostic Business (2019-2024)
Figure 48. Abbott Laboratories Revenue Growth Rate in Influenza Daignostic Business (2019-2024)
Figure 49. Danaher Corporation Revenue Growth Rate in Influenza Daignostic Business (2019-2024)
Figure 50. Bio-Rad Laboratories Revenue Growth Rate in Influenza Daignostic Business (2019-2024)
Figure 51. BIOMÉRIEUX Revenue Growth Rate in Influenza Daignostic Business (2019-2024)
Figure 52. Roche Revenue Growth Rate in Influenza Daignostic Business (2019-2024)
Figure 53. Becton Dickinson And Company Revenue Growth Rate in Influenza Daignostic Business (2019-2024)
Figure 54. Meridian Bioscience Revenue Growth Rate in Influenza Daignostic Business (2019-2024)
Figure 55. Quidel Corporation Revenue Growth Rate in Influenza Daignostic Business (2019-2024)
Figure 56. Hologic Revenue Growth Rate in Influenza Daignostic Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
